Monoclonal antibody treatment is a medicine used to treat COVID-positive individuals who are symptomatic and have certain medical conditions that may result in a higher risk of hospitalization.
Patients must be referred by a licensed health care provider to be considered for antibody therapy. Due to limited supplies of the specific antibody therapy effective against the rapidly spreading omicron variant, all referrals will be screened to ensure the therapy is used for those individuals at highest risk.